These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 30386144)
1. Comparison of Combined Therapy Using Conventional Chemoembolization and Radiofrequency Ablation Versus Conventional Chemoembolization for Ultrasound-Invisible Early-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Cancer Stage 0 or A). Lee H; Yoon CJ; Seong NJ; Jeong SH; Kim JW Korean J Radiol; 2018; 19(6):1130-1139. PubMed ID: 30386144 [TBL] [Abstract][Full Text] [Related]
2. Early Stage Hepatocellular Carcinomas Not Feasible for Ultrasound-Guided Radiofrequency Ablation: Comparison of Transarterial Chemoembolization Alone and Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation. Hyun D; Cho SK; Shin SW; Park KB; Park HS; Choo SW; Do YS; Choo IW; Lee MW; Rhim H; Lim HK Cardiovasc Intervent Radiol; 2016 Mar; 39(3):417-25. PubMed ID: 26246215 [TBL] [Abstract][Full Text] [Related]
3. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes. Hyun D; Cho SK; Shin SW; Park KB; Lee SY; Park HS; Do YS Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691 [TBL] [Abstract][Full Text] [Related]
4. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm. Yan JY; Zhang JL; Wang MQ; Yuan K; Bai YH; Wang Y; Xin HN; Wang ZJ; Liu FY; Duan F; Fu JX Asia Pac J Clin Oncol; 2018 Aug; 14(4):300-309. PubMed ID: 29124894 [TBL] [Abstract][Full Text] [Related]
5. Viable hepatocellular carcinoma around retained iodized oil after transarterial chemoembolization: radiofrequency ablation of viable tumor plus retained iodized oil versus viable tumor alone. Kim JH; Kim PN; Won HJ; Shin YM AJR Am J Roentgenol; 2014 Nov; 203(5):1127-31. PubMed ID: 25341154 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas. Zheng L; Li HL; Guo CY; Luo SX Korean J Radiol; 2018; 19(2):237-246. PubMed ID: 29520181 [TBL] [Abstract][Full Text] [Related]
7. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study. Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620 [TBL] [Abstract][Full Text] [Related]
8. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching. Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976 [TBL] [Abstract][Full Text] [Related]
9. Treatment of hepatocellular carcinoma in the caudate lobe: US-guided percutaneous radiofrequency ablation combined with ethanol ablation. Liu B; Long J; Wang W; Huang G; Jiang C; Zhang X; Liu M; Liang P; Yu J; Xie X; Kuang M Clin Radiol; 2018 Jul; 73(7):647-656. PubMed ID: 29627066 [TBL] [Abstract][Full Text] [Related]
10. Iodized Oil Transarterial Chemoembolization and Radiofrequency Ablation for Small Periportal Hepatocellular Carcinoma: Comparison with Nonperiportal Hepatocellular Carcinoma. Lee SY; Hyun D; Cho SK; Shin SW; Jung SH; Chi SA Cardiovasc Intervent Radiol; 2018 Jan; 41(1):120-129. PubMed ID: 28924943 [TBL] [Abstract][Full Text] [Related]
11. The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion. Peng Z; Wu X; Li J; Pang H; Zhang Y; Lin M; Wang Z; Xiao H; Li B; Chen M; Feng S; Kuang M; Chen S Int J Hyperthermia; 2022; 39(1):688-696. PubMed ID: 35469522 [TBL] [Abstract][Full Text] [Related]
12. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis. Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment. Kim AR; Park E; Kwon SY; Park SJ; Kim YJ; Yoo BC; Choe WH; Kim JH; Hwang JH; Park SW; Kim YJ; Park HS; Yu MH; Jeon HJ Korean J Gastroenterol; 2019 Mar; 73(3):167-176. PubMed ID: 31013560 [TBL] [Abstract][Full Text] [Related]
14. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study. Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917 [TBL] [Abstract][Full Text] [Related]
15. Computed tomographic-guided radiofrequency ablation of recurrent or residual hepatocellular carcinomas around retained iodized oil after transarterial chemoembolization. Koh YH; Choi JI; Kim HB; Kim MJ Korean J Radiol; 2013; 14(5):733-42. PubMed ID: 24043966 [TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation for viable hepatocellular carcinoma around retained iodized oil after transcatheter arterial chemoembolization: usefulness of biplane fluoroscopy plus ultrasound guidance. Min JH; Lee MW; Rhim H; Choi D; Kim YS; Kim YJ; Cha DI; Lim HK Korean J Radiol; 2012; 13(6):784-94. PubMed ID: 23118578 [TBL] [Abstract][Full Text] [Related]
17. Conventional versus drug-eluting beads chemoembolization for hepatocellular carcinoma: Emphasis on the impact of tumor size. Lee YK; Jung KS; Kim DY; Choi JY; Kim BK; Kim SU; Park JY; Ahn SH; Han KH; Kim GM; Kim MD; Park SI; Won JY; Lee DY J Gastroenterol Hepatol; 2017 Feb; 32(2):487-496. PubMed ID: 27503585 [TBL] [Abstract][Full Text] [Related]
18. Single- versus Triple-Drug Chemoembolization for Hepatocellular Carcinoma: Comparing Outcomes by Toxicity, Imaging Response, and Survival. Mouli SK; Hickey R; Thornburg B; Sato KT; Desai K; Gabr A; Kallini JR; Niemeri H; Kircher S; Mulcahy MF; Benson Iii AB; Gupta R; Salem R; Lewandowski RJ J Vasc Interv Radiol; 2016 Sep; 27(9):1279-1287. PubMed ID: 27062355 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma. Endo K; Kuroda H; Oikawa T; Okada Y; Fujiwara Y; Abe T; Sato H; Sawara K; Takikawa Y Scand J Gastroenterol; 2018 Dec; 53(12):1575-1583. PubMed ID: 30577723 [TBL] [Abstract][Full Text] [Related]
20. Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma: Does the Degree of Ethiodized Oil Accumulation within the Tumor Affect the Therapeutic Efficacy? Lee JE; Kim JW; Kim HO; Lee BC; Hur YH; Cho SB; Cho YS; Seon HJ; Kim D J Vasc Interv Radiol; 2019 Mar; 30(3):370-379.e4. PubMed ID: 30819479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]